A Risk Sciences International news item posted on December 12, 2016 and last updated on August 18, 2019

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.

http://www.nytimes.com/2016/12/12/health/one-in-6-american-adults-say-they-have-taken-psychiatric-drugs-report-says.html

http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/

To read the journal article, click here.

 

 

 

 

More RSI News

Principles of risk decision-making

August 19, 2022

RSI investigators propose fundamental principles of risk decision-making, and explore their application in a range of real-world risk decision-making contexts. These ten principles will provide valuable guidance on addressing current and future risk issues facing civil societies worldwide.

Risk of Myocarditis and Pericarditis

May 11, 2022

Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of…

Quinolones and risk of retinal detachment

April 26, 2022

Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel…

Value of information

April 22, 2022

Risk Sciences International (RSI) investigators Greg Paoli, Shintaro Hagiwara and Daniel Krewski collaborated with investigators from the US Center for Computational Toxicology and Exposure (CCTE)…